Accepted for/Published in: JMIR Formative Research
Date Submitted: Jan 14, 2021
Date Accepted: Apr 22, 2021
Date Submitted to PubMed: May 25, 2021
Acceptability of Research and Healthcare Visits During the COVID-19 Pandemic: A Cross-Sectional Study
ABSTRACT
Background:
The coronavirus disease 2019 (COVID-19) pandemic has had a widespread impact on attendance at biomedical research and healthcare visits.
Objective:
The current study aimed to identify when and how American adults might feel comfortable resuming in-person research and healthcare visits.
Methods:
Cross-sectional questionnaire data were collected from 135 adults (median age=48, 83.7% women, 68.2% White) engaged in health-related research.
Results:
Over half of respondents felt that COVID-19 positively affected their desire to participate in research. Although 73.6% of respondents also indicated willingness to attend in-person healthcare visits when Centers for Disease Control (CDC) guidelines were implemented, 85.8% indicated willingness to attend in-person outdoor visits and 92.2% reported willingness to attend drive-thru visits (both with CDC-guidelines implemented). Videoconferencing was the most preferred format for intervention visits; however, adults over the age of 65 preferred this format less than younger adults, P=.001.
Conclusions:
Researchers and clinicians should continue to provide opportunities for remote-based interventions while enforcing CDC guidelines at in-person visits
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.